Skip to main content
Fig. 3 | Acta Neuropathologica Communications

Fig. 3

From: Complement regulator CD59 prevents peripheral organ injury in rats made seropositive for neuromyelitis optica immunoglobulin G

Fig. 3

Immunofluorescence in skeletal muscle at 24 h after intraperitoneal AQP4-IgG administration. a AQP4 and myosin-II immunofluorescence of tibialis anterior muscle, representative of 4–6 rats per group. b Relative AQP4 immunofluorescence (mean ± S.E.M., 4–6 rats per group, ** P < 0.01 compared to control IgG group). c Immunofluorescence of front limb (triceps brachii), back (latissimus dorsi) and diaphragm muscle in AQP4-IgG-treated CD59+/+ and CD59−/− rats as in panel a, representative of 3 rats. d AQP4, hIgG, C5b-9 and CD45 immunofluorescence in tibialis anterior muscle. Representative of 3 rats per group

Back to article page